Corrigendum to “Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori”
First published: 25 May 2021
In the article titled “Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori” [1], there was an error in Subjects and Methods. This error is shown below:
“(Wyeth-Palace Pharmaceutical Co., Ltd, 1.0g, BID)” should read “(Wyeth-Palace Pharmaceutical Co., Ltd, 0.1 g, BID).”
